Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
AML (Acute Myeloid Leukemia)
Dresden
AML (Acute Myeloid Leukemia) Clinical Trials in Dresden
1 recruiting
Dresden, Germany
Showing
1–1
of
1
trials
Recruiting
Phase 2
Gilteritinib in Combination With Venetoclax and Azacitidine for AML Patients With FLT3 Mutations Ineligible for Intensive Treatment
AML (Acute Myeloid Leukemia)
Technische Universität Dresden
60 enrolled
1 location
NCT06696183
Feedback